GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » Cyclically Adjusted PB Ratio

Enzo Biochem (FRA:EZB) Cyclically Adjusted PB Ratio : 0.71 (As of Jun. 08, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Enzo Biochem's current share price is €1.06. Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 was €1.50. Enzo Biochem's Cyclically Adjusted PB Ratio for today is 0.71.

The historical rank and industry rank for Enzo Biochem's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:EZB' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.63   Med: 1.67   Max: 5.26
Current: 0.69

During the past years, Enzo Biochem's highest Cyclically Adjusted PB Ratio was 5.26. The lowest was 0.63. And the median was 1.67.

FRA:EZB's Cyclically Adjusted PB Ratio is ranked better than
77.21% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.01 vs FRA:EZB: 0.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Enzo Biochem's adjusted book value per share data for the three months ended in Jan. 2024 was €1.287. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.50 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Enzo Biochem's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Cyclically Adjusted PB Ratio Chart

Enzo Biochem Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 1.46 2.09 1.50 0.93

Enzo Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 1.61 0.93 0.83 0.77

Competitive Comparison of Enzo Biochem's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Cyclically Adjusted PB Ratio falls into.



Enzo Biochem Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Enzo Biochem's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.06/1.5
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzo Biochem's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Enzo Biochem's adjusted Book Value per Share data for the three months ended in Jan. 2024 was:

Adj_Book=Book Value per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=1.287/130.1244*130.1244
=1.287

Current CPI (Jan. 2024) = 130.1244.

Enzo Biochem Quarterly Data

Book Value per Share CPI Adj_Book
201404 0.627 100.023 0.816
201407 0.617 100.520 0.799
201410 0.637 100.176 0.827
201501 0.662 98.604 0.874
201504 0.683 99.824 0.890
201507 0.841 100.691 1.087
201510 0.913 100.346 1.184
201601 1.088 99.957 1.416
201604 1.009 100.947 1.301
201607 1.752 101.524 2.246
201610 1.736 101.988 2.215
201701 1.781 102.456 2.262
201704 1.780 103.167 2.245
201707 1.657 103.278 2.088
201710 1.618 104.070 2.023
201801 1.536 104.578 1.911
201804 1.493 105.708 1.838
201807 1.472 106.324 1.802
201810 1.395 106.695 1.701
201901 1.252 106.200 1.534
201904 1.703 107.818 2.055
201907 1.614 108.250 1.940
201910 1.489 108.577 1.784
202001 1.342 108.841 1.604
202004 1.197 108.173 1.440
202007 1.060 109.318 1.262
202010 1.047 109.861 1.240
202101 1.052 110.364 1.240
202104 1.120 112.673 1.293
202107 1.197 115.183 1.352
202110 1.187 116.696 1.324
202201 1.188 118.619 1.303
202204 1.182 121.978 1.261
202207 1.099 125.002 1.144
202210 0.937 125.734 0.970
202301 0.625 126.223 0.644
202304 0.348 127.992 0.354
202307 1.419 128.974 1.432
202310 1.393 129.810 1.396
202401 1.287 130.124 1.287

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (FRA:EZB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Enzo Biochem Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem (FRA:EZB) Business Description

Traded in Other Exchanges
Address
527 Madison Avenue, New York, NY, USA, 10022
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines